Founderland Logofounderland
the ★ top ★ 100 ★ marketers ★
SavedSearch
FoundersFounders
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Product Launches
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Investment News
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Research & Innovation
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
FoundersFounders
Return

Company Page

Waiv

Founders

Meriem Sefta

Waiv is a Paris-based AI precision testing company spun out of Owkin (formerly Owkin Dx) that develops clinical-grade AI diagnostics for oncology. Its platform analyzes digital histopathology images and multimodal patient data to identify biomarkers, predict treatment response, and stratify patients for precision medicine. Waiv's Destra deployment platform integrates seamlessly into existing digital pathology workflows, and the company holds active pharma partnerships with MSD, Merck, and AstraZeneca.

Company Founded in 2026

Healthtech & Biotech iconHealthtech & Biotech

Articles about Waiv

Waiv Spins Out from Owkin with $33M for AI Cancer Diagnostics

Waiv Spins Out from Owkin with $33M for AI Cancer Diagnostics

Healthtech & Biotech iconHealthtech & BiotechMar 17, 2026

About

Dreamwell AIContact UsOur Story

Articles

Product LaunchesInvestment NewsResearch & Innovation

founderland

We Use Cookies

We baked up some cookies – the digital kind. They help Draper run like a well-oiled mid-century machine. Some are essential to the experience, others help us tailor things to your taste. We promise, no crumbs on your blazer. Take a moment to choose what works for you.